You are here:- Resources .. Resource Centre .. HIV .. HIV Test types and innovation

HIV Test types and innovation

Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States 
A. B. Hutchinson, P. G. Farnham, S. L. Sansom, E. Yaylali and J. H. Mermin
Journal of acquired immune deficiency syndromes (1999) Mar 1 2016;71(3):323-30. doi: 10.1097/qai.0000000000000838

Modeling and Cost-Effectiveness in HIV Prevention 
M. M. Jacobsen and R. P. Walensky
Current HIV/AIDS reports Jan 30 2016;():. doi: 10.1007/s11904-016-0303-2

Novel emergency department registration kiosk for HIV screening is cost-effective 
Y. H. Hsieh, D. R. Holtgrave, S. Peterson, C. A. Gaydos and R. E. Rothman
AIDS care Apr 2016;28(4):483-6. doi: 10.1080/09540121.2015.1099603 Epub 2015 Oct 18

HIV pre-test practices: an online survey examining perceptions of informed consent and pre-test information delivery in health care settings across the WHO European Region 
S. Bell, J. Casabona, N. Tsereteli, D. Raben and J. de Wit
Feb 27 2016;():. doi: 10.1177/0956462416636314

Low HIV testing uptake following diagnosis of a sexually transmitted infection in Spain: implications for the implementation of efficient strategies to reduce the undiagnosed HIV epidemic 
S. Fernandez-Balbuena, J. Hoyos, M. E. Rosales-Statkus, A. Nardone, F. Vallejo, M. Ruiz, R. Sanchez, M. J. Belza, B. I. Indave, J. Gutierrez, J. Alvarez and L. Sordo
Feb 3 2016;():1-7. doi: 10.1080/09540121.2015.1123808

Facilitators and Barriers to HIV Screening: A Qualitative Meta-Synthesis 
N. M. Leblanc, D. D. Flores and J. Barroso
Feb 2016;26(3):294-306. doi: 10.1177/1049732315616624

The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States 
M. Shah, K. Risher, S. A. Berry and D. W. Dowdy
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jan 15 2016;62(2):220-9. doi: 10.1093/cid/civ801 Epub 2015 Sep 11

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013 
P. Sobrino-Vegas, S. Moreno, R. Rubio, P. Viciana, J. I. Bernardino, J. R. Blanco, E. Bernal, V. Asensi, F. Pulido, J. Del Amo and V. Hernando
Feb 24 2016;():. doi: 10.1016/j.jinf.2016.01.017

Evaluating the persuasiveness of an HIV mass communication campaign using gain-framed messages and aimed at creating a superordinate identity 
G. Prati, D. Mazzoni, E. Cicognani, C. Albanesi and B. Zani
Feb 9 2016;():1-8. doi: 10.1080/10410236.2015.1040983

How many people are living with undiagnosed HIV infection? an estimate for Italy, based on surveillance data 
A. Mammone, P. Pezzotti, V. Regine, L. Camoni, V. Puro, G. Ippolito, B. Suligoi and E. Girardi
Jan 23 2016;():. doi: 10.1097/qad.0000000000001034

Estimated cost per HIV infection diagnosed through routine HIV testing offered in acute general medical admission units and general practice settings in England 
K. J. Ong, A. C. Thornton, M. Fisher, R. Hutt, S. Nicholson, A. Palfreeman, N. Perry, G. Stedman-Bryce, P. Wilkinson, V. Delpech and A. Nardone
Apr 2016;17(4):247-54. doi: 10.1111/hiv.12293 Epub 2015 Sep 23

Qualitative research on point-of-care testing strategies and programs for HIV 
N. Engel and N. Pant Pai
Jan 2015;15(1):71-5. doi: 10.1586/14737159.2015.960518 Epub 2014 Sep 30

Patients' understanding of blood tests and attitudes to HIV screening in the emergency department of a Swiss teaching hospital: a cross-sectional observational study 
T. Favre-Bulle, D. Baudat, K. E. Darling, R. Mamin, S. Peters, M. Cavassini and O. Hugli
2015;145():w14206. doi: 10.4414/smw.2015.14206

Raising the bar for testing 
E. Cole
Feb 17 2015;29(24):24-5. doi: 10.7748/ns.29.24.24.s28

Active recall to increase HIV and STI testing: a systematic review 
M. Desai, S. C. Woodhall, A. Nardone, F. Burns, D. Mercey and R. Gilson
Aug 2015;91(5):314-23. doi: 10.1136/sextrans-2014-051930 Epub 2015 Mar 10

Effectiveness of a pilot partner notification program for new HIV cases in Barcelona, Spain 
P. Garcia de Olalla, E. Molas, M. J. Barbera, S. Martin, E. Arellano, M. Gosch, P. Saladie, T. Carbonell, H. Knobel, E. Diez and J. A. Cayla
2015;10(4):e0121536. doi: 10.1371/journal.pone.0121536

[Indicator-based HIV testing] 
B. R. Hansen, A. B. Andersen, A. Koch, P. Ravn, C. S. Larsen, N. Weis and J. Gerstoft
Sep 7 2015;177(37):V03150266. doi:

Tailoring HIV testing in a setting of late HIV diagnosis: is the tide turning? 
J. Freer, M. Lascar and E. Phiri
Oct 2015;76(10):592-5. doi: 10.12968/hmed.2015.76.10.592

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center 
P. Gantner, M. Treger, C. De Miscault, M. L. Batard, C. Bernard-Henry, C. Cheneau, E. De Mautort, M. Partisani, M. Priester and D. Rey
2015;10(12):e0145440. doi: 10.1371/journal.pone.0145440

The cascade of care in the Eastern European country of Georgia 
N. Chkhartishvili, L. Sharavdze, O. Chokoshvili, J. A. DeHovitz, C. del Rio and T. Tsertsvadze
Jan 2015;16(1):62-6. doi: 10.1111/hiv.12172 Epub 2014 Jun 12

Financial incentives to improve progression through the HIV treatment cascade 
I. V. Bassett, D. Wilson, J. Taaffe and K. A. Freedberg
Nov 2015;10(6):451-63. doi: 10.1097/coh.0000000000000196

TestMeEast: a campaign to increase HIV testing in hospitals and to reduce late diagnosis 
R. Bath, R. O'Connell, M. Lascar, R. Ferrand, S. Strachan, N. Matin, I. Bassnet and C. Orkin
Dec 23 2015;():1-4. doi: 10.1080/09540121.2015.1120855

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013 

Nov 26 2015;20(47):. doi: 10.2807/

Factors responsible for incomplete linkage to care after HIV diagnosis: preliminary results from the Test and Keep in Care (TAK) project 
M. Ankiersztejn-Bartczak, E. Firlag-Burkacka, H. Czeszko-Paprocka, J. Kubicka, A. Cybula, A. Horban and J. D. Kowalska
Feb 2015;16(2):88-94. doi: 10.1111/hiv.12175 Epub 2014 Aug 15

Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC 
A. D. Castel, S. Choi, A. Dor, J. Skillicorn, J. Peterson, N. Rocha and M. Kharfen
PloS one 2015;10(10):e0139605. doi: 10.1371/journal.pone.0139605

[Indicator condition guided human immunodeficiency virus requesting in primary health care: results of a collaboration] 
L. Cayuelas-Redondo, I. Menacho-Pascual, P. Noguera-Sanchez, C. Goicoa-Gago, G. Pollio-Pena, R. Blanco-Delgado, O. Barba-Avila, E. Sequeira-Aymar, M. Muns, T. Clusa, F. Garcia and A. Leon
Dec 2015;33(10):656-62. doi: 10.1016/j.eimc.2015.01.020 Epub 2015 Mar 11

Factors impacting HIV testing: a review--perspectives from Australia, Canada, and the UK 
K. Bolsewicz, A. Vallely, J. Debattista, A. Whittaker and L. Fitzgerald
2015;27(5):570-80. doi: 10.1080/09540121.2014.986050

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage 
J. Bottero, A. Boyd, J. Gozlan, F. Carrat, J. Nau, M. D. Pauti, H. Rougier, P. M. Girard and K. Lacombe
Dec 2015;2(4):ofv162. doi: 10.1093/ofid/ofv162

Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme 
A. Hatzakis, V. Sypsa, D. Paraskevis, G. Nikolopoulos, C. Tsiara, K. Micha, A. Panopoulos, M. Malliori, M. Psichogiou, A. Pharris, L. Wiessing, M. van de Laar, M. Donoghoe, D. D. Heckathorn, S. R. Friedman and D. C. Des Jarlais
Sep 2015;110(9):1453-67. doi: 10.1111/add.12999 Epub 2015 Jul 14

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014 
R. Simmons, R. Malyuta, N. Chentsova, A. Medoeva, Y. Kruglov, A. Yurchenko, A. Copas and K. Porter
2015;10(8):e0137062. doi: 10.1371/journal.pone.0137062

[High time for an HIV test!] 
P. Stiefelhagen
Jul 23 2015;157(13):28. doi: 10.1007/s15006-015-3336-3

Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs 
B. R. Schackman, J. A. Leff, D. M. Barter, M. A. DiLorenzo, D. J. Feaster, L. R. Metsch, K. A. Freedberg and B. P. Linas
Addiction (Abingdon, England) Jan 2015;110(1):129-43. doi: 10.1111/add.12754

Implementing HIV Testing in Substance Use Treatment Programs: A Systematic Review 
C. A. Simeone, S. M. Seal and C. Savage
The Journal of the Association of Nurses in AIDS Care : JANAC Dec 2 2015;():. doi: 10.1016/j.jana.2015.11.006

A new approach to prevent HIV transmission: Project Protect intervention for recently infected individuals 
T. I. Vasylyeva, S. R. Friedman, P. Smyrnov and K. Bondarenko
2015;27(2):223-8. doi: 10.1080/09540121.2014.947913 Epub 2014 Sep 22

Development and psychometric testing of a barriers to HIV testing scale among individuals with HIV infection in Sweden; The Barriers to HIV testing scale-Karolinska version 
M. Wiklander, J. Brannstrom, V. Svedhem and L. E. Eriksson
2015;13(1):185. doi: 10.1186/s12955-015-0381-7

[Earlier case finding and immediate treatment of HIV: Time2Act] 
J. E. van Bergen
2015;159():A9487. doi:

Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data 
A. van Sighem, F. Nakagawa, D. De Angelis, C. Quinten, D. Bezemer, E. O. de Coul, M. Egger, F. de Wolf, C. Fraser and A. Phillips
Sep 2015;26(5):653-60. doi: 10.1097/ede.0000000000000324

Internet-based recruitment system for HIV and STI screening for men who have sex with men in Estonia, 2013: analysis of preliminary outcomes 
K. Ruutel, L. Lohmus and J. Janes
2015;20(15):. doi:

HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care 
I. K. Joore, D. L. Arts, M. J. Kruijer, E. P. Moll van Charante, S. E. Geerlings, J. M. Prins and J. E. van Bergen
Nov 2015;91(7):467-72. doi: 10.1136/sextrans-2015-052073 Epub 2015 Jun 30

Cost and threshold analysis of positive charge, a multi-site linkage to HIV care program in the United States 
J. J. Kim, C. Maulsby, R. Zulliger, K. Jain, V. Charles, M. Riordan, M. Davey-Rothwell and D. R. Holtgrave
AIDS and behavior Oct 2015;19(10):1735-41. doi: 10.1007/s10461-015-1124-9

A systematic review on cost effectiveness of HIV prevention interventions in the United States 
Y. L. Huang, A. Lasry, A. B. Hutchinson and S. L. Sansom
Applied health economics and health policy Apr 2015;13(2):149-56. doi: 10.1007/s40258-014-0142-5

Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge 
K. M. Jain, R. Zulliger, C. Maulsby, J. J. Kim, V. Charles, M. Riordan and D. Holtgrave
AIDS and behavior Nov 12 2015;():. doi: 10.1007/s10461-015-1243-3

A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care 
K. E. Muessig, M. Nekkanti, J. Bauermeister, S. Bull and L. B. Hightow-Weidman
Mar 2015;12(1):173-90. doi: 10.1007/s11904-014-0239-3

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study 
D. Raben, A. Mocroft, M. Rayment, V. M. Mitsura, V. Hadziosmanovic, Z. M. Sthoeger, A. Palfreeman, S. Morris, G. Kutsyna, A. Vassilenko, J. Minton, C. Necsoi, V. P. Estrada, A. Grzeszczuk, V. S. Johansson, J. Begovac, E. L. Ong, A. Cabie, F. Ajana, B. M. Celesia, F. Maltez, M. Kitchen, L. Comi, U. B. Dragsted, N. Clumeck, J. Gatell, B. Gazzard, A. d'Arminio Monforte, J. Rockstroh, Y. Yazdanpanah, K. Champenois, M. L. Jakobsen, A. Sullivan and J. D. Lundgren
2015;10(11):e0140845. doi: 10.1371/journal.pone.0140845

Counseling, screening, and therapy for newly-diagnosed HIV patients 
J. Kwong and S. Gabler
Oct 16 2015;40(10):34-43; quiz 43-4. doi: 10.1097/01.NPR.0000471359.56745.e4

Which adults in the Paris metropolitan area have never been tested for HIV? A 2010 multilevel, cross-sectional, population-based study 
V. Massari, A. Lapostolle, M. C. Grupposo, R. Dray-Spira, D. Costagliola and P. Chauvin
2015;15():278. doi: 10.1186/s12879-015-1006-9

Incremental cost per newly diagnosed HIV infection (NDHI): routine (RTS), targeted (TTS), and current clinical practice testing strategies (CPTS) 
C. Gomez-Ayerbe, M. J. Elias, A. Muriel, P. P. Elias, A. Cano, A. Diaz, A. Moreno, J. L. Casado, C. Santos, M. Martinez-Colubi, A. Uranga, F. Dronda and S. Moreno
Journal of the International AIDS Society 2014;17(4 Suppl 3):19606. doi: 10.7448/ias.17.4.19606

The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States 
A. A. Eggman, D. J. Feaster, J. A. Leff, M. R. Golden, P. C. Castellon, L. Gooden, T. Matheson, G. N. Colfax, L. R. Metsch and B. R. Schackman
Sexually transmitted diseases Sep 2014;41(9):545-50. doi: 10.1097/olq.0000000000000168

Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011-2012 
B. Dokuzoguz, V. Korten, D. Gokengin, M. Fincanci, T. Yildirmak, U. N. Kes, N. Tasdelen Fisgin, D. Inan, H. Eraksoy and H. Akalin
2014;17(4 Suppl 3):19595. doi: 10.7448/ias.17.4.19595

Incentivizing HIV/STI testing: a systematic review of the literature 
R. Lee, R. R. Cui, K. E. Muessig, H. Thirumurthy and J. D. Tucker
May 2014;18(5):905-12. doi: 10.1007/s10461-013-0588-8

Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study 
J. D. Kelly, C. Hartman, J. Graham, M. A. Kallen and T. P. Giordano
Sep-Oct 2014;25(5):405-13. doi: 10.1016/j.jana.2013.12.002

Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions 
T. Jiwatram-Negron and N. El-Bassel
Oct 2014;18(10):1864-87. doi: 10.1007/s10461-014-0827-7

WHO 'Treatment as Prevention' guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced 
A. E. Brown, A. Nardone and V. C. Delpech
Jan 14 2014;28(2):281-3. doi: 10.1097/qad.0000000000000137

Using social network methods to reach out-of-care or ART-nonadherent HIV+ injection drug users in Russia: addressing a gap in the treatment cascade 
Y. Amirkhanian, J. Kelly, A. Kuznetsova, A. Meylakhs, A. Yakovlev, V. Musatov and N. Chaika
2014;17(4 Suppl 3):19594. doi: 10.7448/ias.17.4.19594

HIV testing in Lanarkshire 
R. R. Acquah, A. Baggott, C. McGoldrick and N. Kennedy
2014;44(4):278-82. doi: 10.4997/jrcpe.2014.405

HIV testing practices as reported by HIV-infected patients in four European countries 
J. Deblonde, F. F. Hamers, S. Callens, R. Lucas, H. Barros, K. Ruutel, E. Hemminki and M. Temmerman
Apr 2014;26(4):487-96. doi: 10.1080/09540121.2013.841831

Modelling the potential population impact and cost-effectiveness of self-testing for HIV: evaluation of data requirements 
V. Cambiano, S. N. Mavedzenge and A. Phillips
AIDS and behavior Jul 2014;18 Suppl 4():S450-8. doi: 10.1007/s10461-014-0824-x

The utility of short message service (SMS) texts to remind patients at higher risk of STIs and HIV to reattend for testing: a controlled before and after study 
J. Burton, G. Brook, J. McSorley and S. Murphy
Feb 2014;90(1):11-3. doi: 10.1136/sextrans-2013-051228 Epub 2013 Sep 24

Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom 
E. F. Long, R. Mandalia, S. Mandalia, S. S. Alistar, E. J. Beck and M. L. Brandeau
PloS one 2014;9(4):e95735. doi: 10.1371/journal.pone.0095735

How Many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based model 
P. J. White, J. Fox, J. Weber, S. Fidler and H. Ward
The Journal of infectious diseases Dec 1 2014;210 Suppl 2():S594-9. doi: 10.1093/infdis/jiu470

Promoting HIV testing, chlamydia testing and long-acting reversible contraception 
A. Tear, J. Herbert and P. Oakeshott
May 2014;90(3):207. doi: 10.1136/sextrans-2014-051505

[Diagnosing HIV in Switzerland] 
J. Schupbach, C. Berger, J. Boni and R. F. Speck
Aug 2014;71(8):451-60. doi: 10.1024/0040-5930/a000537

Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies 
Y. Yazdanpanah and K. Champenois
Jul 31 2014;28(12):1831-3. doi: 10.1097/qad.0000000000000271

Use of rapid HIV testing in a low threshold centre in Antwerp, Belgium, 2007-2012 
K. Wouters, K. Fransen, G. Beelaert, C. Kenyon, T. Platteau, C. Van Ghyseghem, I. Collier, J. Buyze and E. Florence
Nov 2014;25(13):936-42. doi: 10.1177/0956462414526705

Does this adult patient have early HIV infection?: The Rational Clinical Examination systematic review 
E. Wood, T. Kerr, G. Rowell, J. S. Montaner, P. Phillips, P. T. Korthuis and D. L. Simel
Jul 16 2014;312(3):278-85. doi: 10.1001/jama.2014.5954

Predictors of advanced disease and late presentation in new HIV diagnoses reported to the surveillance system in Spain 
J. Oliva, M. Diez, S. Galindo, C. Cevallos, A. Izquierdo, J. Cereijo, A. Arrillaga, A. Nicolau, A. Fernandez, M. Alvarez, J. Castilla, E. Martinez, I. Lopez and N. Vives
Mar-Apr 2014;28(2):116-22. doi: 10.1016/j.gaceta.2013.06.009 Epub 2013 Dec 21

Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital 
V. Mosimann, M. Cavassini, O. Hugli, R. Mamin, C. Achtari, S. Peters and K. E. Darling
Nov 2014;15(10):631-4. doi: 10.1111/hiv.12181

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing 
A. Mena, L. Moldes, H. Meijide, A. Canizares, A. Castro-Iglesias, M. Delgado, S. Pertega, J. Pedreira, G. Bou and E. Poveda
2014;9(12):e113062. doi: 10.1371/journal.pone.0113062

[Late diagnosis of HIV infection: missed diagnostic opportunities] 
M. Rivero Marcotegui, E. Layana Echezuri, J. Reparaz Padros, C. Irigoyen Olaiz, M. Arraiza Cruchaga and J. Uriz Ayestaran
Sep-Dec 2014;37(3):329-38. doi:

Trends in HIV diagnoses, HIV care, and uptake of antiretroviral therapy among heterosexual adults in England, Wales, and Northern Ireland 
B. Rice, J. Elford, Z. Yin, S. Croxford, A. Brown and V. Delpech
Apr 2014;41(4):257-65. doi: 10.1097/olq.0000000000000111

The cascade of HIV care in Russia, 2011-2013 
A. Pokrovskaya, A. Popova, N. Ladnaya and O. Yurin
2014;17(4 Suppl 3):19506. doi: 10.7448/ias.17.4.19506

Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department 
J. S. Haukoos, J. D. Campbell, A. A. Conroy, E. Hopkins, M. M. Bucossi, C. Sasson, A. A. Al-Tayyib and M. W. Thrun
PloS one 2013;8(12):e81565. doi: 10.1371/journal.pone.0081565

5.6. Implications for Service Provision in Lanarkshire 
J. Frankis, P. Flowers, K. Lorimer and M. Davis
2013;():160-165. doi:

Testing times: testing patient acceptance and ability to self-screen for a No-Talk Testing service 
I. Fernando and C. Thompson
May 2013;24(5):341-4. doi: 10.1177/0956462412472835 Epub 2013 Jun 19

The case for indicator condition-guided HIV screening 
J. V. Lazarus, M. Hoekstra, D. Raben, V. Delpech, T. Coenen and J. D. Lundgren
Aug 2013;14(7):445-8. doi: 10.1111/hiv.12022 Epub 2013 Mar 10

Social network approaches to recruitment, HIV prevention, medical care, and medication adherence 
C. A. Latkin, M. A. Davey-Rothwell, A. R. Knowlton, K. A. Alexander, C. T. Williams and B. Boodram
Jun 1 2013;63 Suppl 1():S54-8. doi: 10.1097/QAI.0b013e3182928e2a

Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV 
A. B. Hutchinson, S. F. Ethridge, L. G. Wesolowski, R. K. Shrestha, M. Pentella, B. Bennett, P. G. Farnham, T. Sullivan, P. Patel and B. M. Branson
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology Dec 2013;58 Suppl 1():e2-7. doi: 10.1016/j.jcv.2013.10.005

What do patients think about HIV mass screening in France? A qualitative study 
M. P. Fernandez-Gerlinger, E. Bernard and O. Saint-Lary
2013;13():526. doi: 10.1186/1471-2458-13-526

Molecular HIV screening 
T. Bourlet, M. Memmi, H. Saoudin and B. Pozzetto
Sep 2013;13(7):693-705. doi: 10.1586/14737159.2013.829703

[Facilitators and barriers to HIV testing: a literature review] 
A. X. Araya, P. Bravo, P. Carrasco, M. T. Urrutia, P. Vega, M. Rubio and M. J. Lira
Dec 2013;30(6):638-43. doi: 10.4067/s0716-10182013000600011

HIV testing in Greece: repeating past mistakes 

Jul 13 2013;382(9887):102. doi: 10.1016/s0140-6736(13)61546-9

Quality of HIV care in the United Kingdom: key indicators for the first 12 months from HIV diagnosis 
V. Delpech, A. E. Brown, S. Croxford, C. Chau, V. Polavarapu, N. Cooper, G. Rooney and Z. Yin
Oct 2013;14 Suppl 3():19-24. doi: 10.1111/hiv.12070

Audit of the effect of electronic patient records on uptake of HIV testing in a level 3 genitourinary medicine service 
E. Clarke, S. Bhatt, R. Patel and S. Samraj
Aug 2013;24(8):661-5. doi: 10.1177/0956462413478877 Epub 2013 Jul 19

mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature 
C. Catalani, W. Philbrick, H. Fraser, P. Mechael and D. M. Israelski
2013;7():17-41. doi: 10.2174/1874613620130812003

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study) 
A. K. Sullivan, D. Raben, J. Reekie, M. Rayment, A. Mocroft, S. Esser, A. Leon, J. Begovac, K. Brinkman, R. Zangerle, A. Grzeszczuk, A. Vassilenko, V. Hadziosmanovic, M. Krasnov, A. Sonnerborg, N. Clumeck, J. Gatell, B. Gazzard, Ad Monforte, J. Rockstroh and J. D. Lundgren
2013;8(1):e52845. doi: 10.1371/journal.pone.0052845 Epub 2013 Jan 15

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study) 
A. K. Sullivan, D. Raben, J. Reekie, M. Rayment, A. Mocroft, S. Esser, A. Leon, J. Begovac, K. Brinkman, R. Zangerle, A. Grzeszczuk, A. Vassilenko, V. Hadziosmanovic, M. Krasnov, A. Sonnerborg, N. Clumeck, J. Gatell, B. Gazzard, Ad Monforte, J. Rockstroh and J. D. Lundgren
PloS one 2013;8(1):e52845. doi: 10.1371/journal.pone.0052845 Epub 2013 Jan 15

The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial 
B. R. Schackman, L. R. Metsch, G. N. Colfax, J. A. Leff, A. Wong, C. A. Scott, D. J. Feaster, L. Gooden, T. Matheson, L. F. Haynes, A. D. Paltiel and R. P. Walensky
Drug and alcohol dependence Feb 1 2013;128(1-2):90-7. doi: 10.1016/j.drugalcdep.2012.08.009

Routine HIV screening in Portugal: clinical impact and cost-effectiveness 
Y. Yazdanpanah, J. Perelman, M. A. DiLorenzo, J. Alves, H. Barros, C. Mateus, J. Pereira, K. Mansinho, M. Robine, J. E. Park, E. L. Ross, E. Losina, R. P. Walensky, F. Noubary, K. A. Freedberg and A. D. Paltiel
PloS one 2013;8(12):e84173. doi: 10.1371/journal.pone.0084173

Testing times for HIV 
J. Weber and R. Tatoud
2013;347():f5556. doi: 10.1136/bmj.f5556

Telephone communication of HIV testing results for improving knowledge of HIV infection status 
L. Tudor Car, S. Gentry, M. H. van-Velthoven and J. Car
2013;1():CD009192. doi: 10.1002/14651858.CD009192.pub2

Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview 
B. R. Phelps, S. Ahmed, A. Amzel, M. O. Diallo, T. Jacobs, S. E. Kellerman, M. H. Kim, N. Sugandhi, M. Tam and M. Wilson-Jones
Nov 2013;27 Suppl 2():S207-13. doi: 10.1097/qad.0000000000000095

Which factors may affect the willingness to take the HIV test? A research on Italian adults' sample 
T. Mancini and C. Foa
Aug 2013;84(2):143-54. doi:

The cost-effectiveness of expanded HIV screening in the United States 
A. Lucas and B. Armbruster
AIDS (London, England) Mar 13 2013;27(5):795-801. doi: 10.1097/QAD.0b013e32835c54f9

Surveillance of new HIV infections/diagnoses in Puglia region (south Italy), years 2007-2011 
D. Loconsole, R. Procacci, A. Sallustio, M. Quarto, C. Germinario and M. Chironna
Jul-Aug 2013;25(4):291-8. doi: 10.7416/ai.2013.1931

HIV testing for acute medical admissions: evaluation of a pilot study in Leicester, England 
A. Palfreeman, F. Nyatsanza, H. Farn, G. McKinnon, P. Schober and P. McNally
Sexually transmitted infections Jun 2013;89(4):308-10. doi: 10.1136/sextrans-2011-050401

HIV in the UK: test, test, and test again 
A. Nardone, V. Delpech, O. N. Gill, K. A. Fenton and J. Anderson
Nov 23 2013;382(9906):1687-8. doi: 10.1016/s0140-6736(13)62377-6

Predictors of late presentation for HIV diagnosis: a literature review and suggested way forward 
A. Mukolo, R. Villegas, M. Aliyu and K. A. Wallston
Jan 2013;17(1):5-30. doi: 10.1007/s10461-011-0097-6

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users 
L. E. Cipriano, G. S. Zaric, M. Holodniy, E. Bendavid, D. K. Owens and M. L. Brandeau
PloS one 2012;7(9):e45176. doi: 10.1371/journal.pone.0045176 Epub 2012 Sep 18

Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States 
L. Cragin, F. Pan, S. Peng, J. M. Zenilman, J. Green, C. Doucet, D. B. Chalfin and G. de Lissovoy
HIV clinical trials Jan-Feb 2012;13(1):11-22. doi: 10.1310/hct1301-011 10.1310/hct1301-11

HIV diagnoses and missed opportunities. Results of the British HIV Association (BHIVA) National Audit 2010 
S. Ellis, H. Curtis and E. L. Ong
Oct 2012;12(5):430-4. doi:

[HIV test and prevention] 
A. Bickel and P. Vernazza
Oct 2012;53(10):1179-86. doi: 10.1007/s00108-011-2971-8

HIV testing in drug treatment centers proves cost-effective 

AIDS policy & law Nov 2012;28(1):3. doi:

Saliva HIV test nearly as accurate as blood results 

Mar 2012;27(4):1. doi:

Supervised blood-based self-sample collection and rapid test performance: a valuable alternative to the use of saliva by HIV testing programmes with no medical or nursing staff 
M. J. Belza, M. E. Rosales-Statkus, J. Hoyos, P. Segura, E. Ferreras, R. Sanchez, G. Molist and L. de la Fuente
Apr 2012;88(3):218-21. doi: 10.1136/sextrans-2011-050131 Epub 2012 Feb 11

How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings 
P. G. Farnham, S. L. Sansom and A. B. Hutchinson
Medical decision making : an international journal of the Society for Medical Decision Making May-Jun 2012;32(3):459-69. doi: 10.1177/0272989x11431609 Epub 2012 Jan 12

Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis 
N. Pant Pai, B. Balram, S. Shivkumar, J. L. Martinez-Cajas, C. Claessens, G. Lambert, R. W. Peeling and L. Joseph
May 2012;12(5):373-80. doi: 10.1016/s1473-3099(11)70368-1 Epub 2012 Jan 24

Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection 
O. S. Sogaard, N. Lohse, L. Ostergaard, G. Kronborg, B. Roge, J. Gerstoft, H. T. Sorensen and N. Obel
2012;7(3):e32538. doi: 10.1371/journal.pone.0032538

Undiagnosed HIV prevalence in France: no evidence against universal HIV screening 
V. Supervie and D. Costagliola
Nov 28 2012;26(18):2419; author reply 2419-21. doi: 10.1097/QAD.0b013e32835a5bb4

HIV prevention in the context of care: HIV testing and public health practice 
P. O'Byrne
Mar-Apr 2012;29(2):175-84. doi: 10.1111/j.1525-1446.2011.00995.x Epub 2012 Jan 26

Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons 
C. Gopalappa, P. G. Farnham, A. B. Hutchinson and S. L. Sansom
Journal of acquired immune deficiency syndromes (1999) Sep 1 2012;61(1):99-105. doi: 10.1097/QAI.0b013e31825bd862

Return on public health investment: CDC's Expanded HIV Testing Initiative 
A. B. Hutchinson, P. G. Farnham, N. Duffy, R. J. Wolitski, S. L. Sansom, S. W. Dooley, J. C. Cleveland and J. H. Mermin
Journal of acquired immune deficiency syndromes (1999) Mar 1 2012;59(3):281-6. doi: 10.1097/QAI.0b013e31823e5bee

Factors that affect HIV testing and counseling services among heterosexuals in Canada and the United Kingdom: an integrated review 
S. Kaai, S. Bullock, A. N. Burchell and C. Major
Jul 2012;88(1):4-15. doi: 10.1016/j.pec.2011.11.011 Epub 2011 Dec 23

Global income-related inequalities in HIV testing 
A. Larose, S. Moore, S. Harper and J. Lynch
Sep 2011;33(3):345-52. doi: 10.1093/pubmed/fdr001 Epub 2011 Jan 27

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA 
J. L. Juusola, M. L. Brandeau, E. F. Long, D. K. Owens and E. Bendavid
AIDS (London, England) Sep 10 2011;25(14):1779-87. doi: 10.1097/QAD.0b013e328349f067

Ten years of HIV testing with fourth generation assays: the Amsterdam experience 
S. Jurriaans, N. K. Back and K. C. Wolthers
Dec 2011;52 Suppl 1():S67-9. doi: 10.1016/j.jcv.2011.09.021 Epub 2011 Oct 12

Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness 
T. Lorenc, I. Marrero-Guillamon, P. Aggleton, C. Cooper, A. Llewellyn, A. Lehmann and C. Lindsay
Sexually transmitted infections Jun 2011;87(4):272-8. doi: 10.1136/sti.2010.048280 Epub 2011 Mar 25

HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis 
E. F. Long
PloS one 2011;6(11):e27625. doi: 10.1371/journal.pone.0027625 Epub 2011 Nov 16

Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm(3): assessment of need following changes in treatment guidelines 
S. Lodi, A. Phillips, G. Touloumi, R. Geskus, L. Meyer, R. Thiebaut, N. Pantazis, J. D. Amo, A. M. Johnson, A. Babiker and K. Porter
Oct 2011;53(8):817-25. doi: 10.1093/cid/cir494

Prevencija i nadzor zaraznih bolesti među intravenskim korisnicima droga 
European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction
2011;():. doi:

Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department 
D. W. Dowdy, R. M. Rodriguez, C. B. Hare and B. Kaplan
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Jul 2011;18(7):745-53. doi: 10.1111/j.1553-2712.2011.01110.x

Modeling the cost-effectiveness of health programs: HIV testing and early treatment in the USA 
E. J. Beck
Future microbiology Jul 2011;6(7):725-9. doi: 10.2217/fmb.11.63

Diagnosing and treating HIV infection 
M. Jones
Mar 22-28 2011;107(11):12-4. doi:

Cost-effectiveness analysis and HIV screening: the emergency medicine perspective 
H. Hsu and R. P. Walensky
Annals of emergency medicine Jul 2011;58(1 Suppl 1):S145-50. doi: 10.1016/j.annemergmed.2011.03.039

Social and behavioural characteristics of a sample of AIDS Help-Line users never tested for HIV in Italy 
P. Gallo, A. Colucci, L. Camoni, V. Regine, A. M. Luzi and B. Suligoi
Oct 2011;21(5):627-31. doi: 10.1093/eurpub/ckq151 Epub 2010 Oct 13

Cost effectiveness analysis of the New Jersey rapid testing algorithm for HIV testing in publicly funded testing sites 
K. Stevinson, E. G. Martin, S. Marcella and S. M. Paul
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology Dec 2011;52 Suppl 1():S29-33. doi: 10.1016/j.jcv.2011.09.012

Introduction to special supplement. Monitoring and evaluation of HIV counseling, testing and referral (CTR) and HIV testing services 
R. Stein, T. S. Grimes, R. Malow, D. Stratford, F. Spielberg and D. R. Holtgrave
Jun 2011;23(3 Suppl):1-6. doi: 10.1521/aeap.2011.23.3_supp.1

Current and future assays for identifying recent HIV infections at the population level 
J. Smolen-Dzirba and T. J. Wasik
May 2011;17(5):RA124-33. doi:

Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department 
R. P. Walensky, B. L. Morris, W. M. Reichmann, A. D. Paltiel, C. Arbelaez, L. Donnell-Fink, J. N. Katz and E. Losina
PloS one 2011;6(10):e25575. doi: 10.1371/journal.pone.0025575 Epub 2011 Oct 12

Tuberculosis and HIV co-infection: screening and treatment strategies 
K. K. Venkatesh, S. Swaminathan, J. R. Andrews and K. H. Mayer
Jun 18 2011;71(9):1133-52. doi: 10.2165/11591360-000000000-00000

HIV screening programs in US emergency departments: a cross-site comparison of structure, process, and outcomes 
G. W. Torres, J. D. Heffelfinger, H. A. Pollack, S. G. Barrera and R. E. Rothman
Annals of emergency medicine Jul 2011;58(1 Suppl 1):S104-13. doi: 10.1016/j.annemergmed.2011.03.034

HIV exceptionalism and ethical concerns surrounding HIV testing 
K. M. O'Hara
Apr 2011;24(4):66, 68. doi:

Standardised opt-out testing for HIV 
D. Millett
Dec 2011;19(8):14-8. doi: 10.7748/en2011.

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study 
M. May, M. Gompels, V. Delpech, K. Porter, F. Post, M. Johnson, D. Dunn, A. Palfreeman, R. Gilson, B. Gazzard, T. Hill, J. Walsh, M. Fisher, C. Orkin, J. Ainsworth, L. Bansi, A. Phillips, C. Leen, M. Nelson, J. Anderson and C. Sabin
2011;343():d6016. doi: 10.1136/bmj.d6016

Costs and effectiveness of finding new HIV diagnoses by using rapid testing in transgender communities 
R. K. Shrestha, S. L. Sansom, J. D. Schulden, B. Song, L. C. Smith, R. Ramirez, A. Mares-DelGrasso and J. D. Heffelfinger
AIDS education and prevention : official publication of the International Society for AIDS Education Jun 2011;23(3 Suppl):49-57. doi: 10.1521/aeap.2011.23.3_supp.49

Missed opportunities for HIV testing--a costly oversight 
P. Read, D. Armstrong-James, C. Y. Tong and J. Fox
May 2011;104(5):421-4. doi: 10.1093/qjmed/hcq236

Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis 
V. S. Prabhu, P. G. Farnham, A. B. Hutchinson, S. Soorapanth, J. D. Heffelfinger, M. R. Golden, J. T. Brooks, D. Rimland and S. L. Sansom
PloS one 2011;6(5):e19936. doi: 10.1371/journal.pone.0019936 Epub 2011 May 20

 New report: The HIV in Europe initiative - the first 10 years
Tuesday, January 31, 2017

2017 marks 10 years of HIV in Europe - read about the 10 years of working with different stakeholders to promote earlier testing and care in our new report

 HepHIV 2017 Malta Conference
Tuesday, January 31, 2017

HepHIV 2017 Conference is now taking place in Malta (31 January - 2 February 2017). See full programme here. You can also follow news and updates on Twitter by following the conference hashtag #HepHIV2017


Copyright 2009 by HIV in Europe
PLay slots online Live dealer casinos